MeiraGTx Announces AAV-CNGA3 Has Received Orphan Drug Designatio
MGTX: MeiraGTx Holdings Plc
2018-08-13 07:00:00
MeiraGTx Announces AAV-CNGA3 Has Received Orphan Drug Designation from the U.S. FDA for the Treatment of Achromatopsia
2018-08-13 07:00:00
MeiraGTx Announces AAV-CNGA3 Has Received Orphan Drug Designation from the U.S. FDA for the Treatment of Achromatopsia